Paper9174176
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.
Hoggard PG and 4 others. Antimicrob Agents Chemother, 1997. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. Papers, record 9174176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9174176
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| Stavudine | Major topic |
| Cells, Cultured | |
| Drug Interactions | |
| Humans | |
| Leukemia, Monocytic, Acute | |
| Leukocytes, Mononuclear | |
| Phosphorylation | |
| Phytohemagglutinins | |
| Stimulation, Chemical | |
| Thymidine | |
| Zidovudine |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7861017 | Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089. | J Infect Dis | 1995 | https://conductscience.org/library/papers/7861017 | PubMed |
| 2 | 7833221 | Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7833221 | PubMed |
| 3 | 7574535 | Drug interactions with zidovudine phosphorylation in vitro. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7574535 | PubMed |
| 4 | 8568296 | Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. | J Infect Dis | 1996 | https://conductscience.org/library/papers/8568296 | PubMed |
| 5 | 8724049 | Interaction between lamivudine (3TC) and other nucleoside analogues for intracellular phosphorylation. | AIDS | 1996 | https://conductscience.org/library/papers/8724049 | PubMed |
| 6 | 8902065 | The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. | AIDS | 1996 | https://conductscience.org/library/papers/8902065 | PubMed |
| 7 | 4813080 | Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses. | J Clin Pharmacol | 1974 | https://conductscience.org/library/papers/4813080 | PubMed |
| 8 | 541423 | Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol. | J Chromatogr | 1979 | https://conductscience.org/library/papers/541423 | PubMed |
| 9 | 6610522 | Fluoxetine kinetics and protein binding in normal and impaired renal function. | Clin Pharmacol Ther | 1984 | https://conductscience.org/library/papers/6610522 | PubMed |
| 10 | 3028398 | Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. | Biochem Biophys Res Commun | 1987 | https://conductscience.org/library/papers/3028398 | PubMed |
| 11 | 2435003 | Ribavirin antagonizes the effect of azidothymidine on HIV replication. | Science | 1987 | https://conductscience.org/library/papers/2435003 | PubMed |
| 12 | 3568539 | Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome. | Clin Pharmacol Ther | 1987 | https://conductscience.org/library/papers/3568539 | PubMed |
| 13 | 3495235 | Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3495235 | PubMed |
| 14 | 3648476 | The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides. | Mol Pharmacol | 1987 | https://conductscience.org/library/papers/3648476 | PubMed |
| 15 | 3120727 | Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity. | Biochem Pharmacol | 1987 | https://conductscience.org/library/papers/3120727 | PubMed |
| 16 | 3435108 | Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3435108 | PubMed |
| 17 | 2536441 | 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent. | J Med Chem | 1989 | https://conductscience.org/library/papers/2536441 | PubMed |
| 18 | 2852679 | Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders. | J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/2852679 | PubMed |
| 19 | 2539371 | Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2539371 | PubMed |
| 20 | 2470825 | Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. | J Immunol Methods | 1989 | https://conductscience.org/library/papers/2470825 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27044763 | KASL clinical practice guidelines: management of hepatitis C. | Clin Mol Hepatol | 2016 | https://conductscience.org/library/papers/27044763 | PubMed |
| 26537918 | Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord. | BMC Infect Dis | 2015 | https://conductscience.org/library/papers/26537918 | PubMed |
| 25032178 | KASL clinical practice guidelines: management of hepatitis C. | Clin Mol Hepatol | 2014 | https://conductscience.org/library/papers/25032178 | PubMed |
| 24550342 | Intracellular effects of the Hepatitis C virus nucleoside polymerase inhibitor RO5855 (Mericitabine Parent) and Ribavirin in combination. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24550342 | PubMed |
| 22344296 | A quantitative basis for antiretroviral therapy for HIV-1 infection. | Nat Med | 2012 | https://conductscience.org/library/papers/22344296 | PubMed |
| 21115794 | In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21115794 | PubMed |
| 20000887 | Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action. | Clin Pharmacokinet | 2010 | https://conductscience.org/library/papers/20000887 | PubMed |
| 19330875 | Diagnosis, management, and treatment of hepatitis C: an update. | Hepatology | 2009 | https://conductscience.org/library/papers/19330875 | PubMed |
| 19273671 | Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19273671 | PubMed |
| 19043930 | Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin. | Antivir Ther | 2008 | https://conductscience.org/library/papers/19043930 | PubMed |
| 18160521 | The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18160521 | PubMed |
| 17638393 | Nucleoside and nucleotide reverse transcriptase inhibitors in children. | Clin Drug Investig | 2007 | https://conductscience.org/library/papers/17638393 | PubMed |
| 17517847 | In vitro interactions between apricitabine and other deoxycytidine analogues. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17517847 | PubMed |
| 17501757 | Therapeutic issues in HIV/HCV-coinfected patients. | J Viral Hepat | 2007 | https://conductscience.org/library/papers/17501757 | PubMed |
| 17242147 | Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17242147 | PubMed |
| 16495240 | Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16495240 | PubMed |
| 16189072 | Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16189072 | PubMed |
| 16091233 | Hepatitis C virus infection in HIV-infected patients. | Curr HIV/AIDS Rep | 2004 | https://conductscience.org/library/papers/16091233 | PubMed |
| 15855513 | Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15855513 | PubMed |
| 15727735 | Management of Hepatitis C in HIV-infected Patients. | Curr Infect Dis Rep | 2005 | https://conductscience.org/library/papers/15727735 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9174176
GET https://conductscience.org/api/papers/v1/9174176/references?page=2